David Wang is a recent graduate of Vanderbilt University with majors in molecular and cellular biology and Spanish. His current project focuses on the optimization and development of plasma AB as a clinical biomarker for Alzheimer’s disease. Specifically, he is investigating lower volumes of plasma for AB detection and quantitation as well as looking at ways to maximize the recovery of AB protein from plasma. He will be pursuing an MD degree at Carver College of Medicine. Outside of the lab, he enjoys traveling, exercising and improving his fluency in Spanish and Chinese.